Associations Between the NLRP3 and IL-1β Gene Polymorphisms and Gout Susceptibility

Objective Gout is a common form of inflammatory arthritis which characteristics by joint and surrounding soft tissues pain with sudden onset,fever,redness and swelling,caused by the monosodium urate crystals deposited.Studies have demonstrated that genetic factors occupies a certain role in the pathogenesis of gout.Therefore,in our study we aimed to explore the associations between the NLRP3 and IL-1β gene polymorphisms and gout susceptibility,in order to provide experimental basis for the diagnosis and treatment of gout furtherly.Methods We selected 715 Han individuals as our research object which included 267 male gout patients and 448 male healthy controls.Recorded demographic informations and collected blood samples.Then measured biochemical indicators and extracted the genomic DNA.The genotypes of NLRP3 gene rs7525979,rs3806268 and rs10754558 loci and IL-1β gene rs16944,rs1143623 and rs1143634 loci were detected through polymerase chain reaction(PCR) amplification technique.All data were analysised used Statistical Package for Social Sciences version 23.0(SPSS 23.0) software.Results The distribution of genotype and allele frequency were significant differences in gout patients and controls for rs3806268 of NLRP3 gene and rs1143634 of IL-1β gene(P༜0.05).NLRP3 gene rs3806268 loci AA genotype compared with GG genotype in additive model(OR = 0.58,95%CI:0.41–0.84) and AA genotype compared with GG + GA genotype in recessive model(OR = 0.61, 95%CI:0.44–0.85) and IL-1β gene rs1143634 loci AA + GA genotype compared with GG genotype in dominant model(OR = 0.45, 95%CI:0.24–0.84) could reduced the risk of gout.TC and LDL-C concentrations were significantly differences when gout patients were divided into AA + GA and GG genotype groups (P༜0.05).Conclusion There are some associations between rs3806268 of NLRP3 gene and rs1143634 of IL-1β gene and gout susceptibility.Rs3806268 and rs1143634 loci variants may be the protect factors of gout.

[1]  D. Leosco,et al.  Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome , 2020, Frontiers in Physiology.

[2]  P. Sandrin-Garcia,et al.  IL1β, IL18, NFKB1 and IFNG gene interactions are associated with severity of rheumatoid arthritis: A pilot study , 2020, Autoimmunity.

[3]  L. AL-Eitan,et al.  The Association of IL-1 and HRAS Gene Polymorphisms with Breast Cancer Susceptibility in a Jordanian Population of Arab Descent: A Genotype–Phenotype Study , 2020, Cancers.

[4]  Eun Hee Ha,et al.  Development of novel NLRP3-XOD dual inhibitors for the treatment of gout. , 2020, Bioorganic & medicinal chemistry letters.

[5]  Qiang Liu,et al.  The prevalence of gout and hyperuricemia in middle-aged and elderly people in Tibet Autonomous Region, China , 2020, Medicine.

[6]  K. Petrie,et al.  Internalized and Anticipated Stigmatization in Patients With Gout , 2019, ACR open rheumatology.

[7]  H. Sayles,et al.  Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality , 2020, Arthritis care & research.

[8]  Chin-Lon Lin,et al.  Vegetarian diet and risk of gout in two separate prospective cohort studies. , 2020, Clinical nutrition.

[9]  Boyi Liu,et al.  Eucalyptol alleviates inflammation and pain responses in a mouse model of gout arthritis , 2019, British journal of pharmacology.

[10]  T. Hosoya,et al.  Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout , 2019, Clinical and Experimental Nephrology.

[11]  L. Joosten,et al.  Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia , 2019, Immunological reviews.

[12]  C. Chien,et al.  Effectiveness of Cherries in Reducing Uric Acid and Gout: A Systematic Review , 2019, Evidence-based complementary and alternative medicine : eCAM.

[13]  K. Fallon,et al.  What factors contribute to uncontrolled gout and hospital admission? A qualitative study of inpatients and their primary care practitioners , 2019, BMJ Open.

[14]  Yuanfei Lu,et al.  Relationship between urate within tophus and bone erosion according to the anatomic location of urate deposition in gout , 2019, Medicine.

[15]  D. van Schaardenburg,et al.  Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review , 2019, Nutrients.

[16]  K. Pavelka,et al.  Interaction of the p.Q141K Variant of the ABCG2 Gene with Clinical Data and Cytokine Levels in Primary Hyperuricemia and Gout , 2019, Journal of clinical medicine.

[17]  Yu Wang,et al.  Cichorium intybus L. Extract Suppresses Experimental Gout by Inhibiting the NF-κB and NLRP3 Signaling Pathways , 2019, International journal of molecular sciences.

[18]  J. Wu,et al.  Decreased Associated Risk of Gout in Diabetes Patients with Uric Acid Urolithiasis , 2019, Journal of clinical medicine.

[19]  J. Choe,et al.  Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7. , 2019, Biochemical and biophysical research communications.

[20]  Hee-Jae Jung,et al.  Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review. , 2019, Journal of autoimmunity.

[21]  Fang Wang,et al.  Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial , 2019, Clinical Rheumatology.

[22]  Sheng-Chia Chung,et al.  Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements , 2019, BMJ Open.

[23]  Y. Kamatani,et al.  Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout , 2019, Annals of the rheumatic diseases.

[24]  Mingliang Zhang,et al.  Chaetocin attenuates gout in mice through inhibiting HIF-1α and NLRP3 inflammasome-dependent IL-1β secretion in macrophages. , 2019, Archives of biochemistry and biophysics.

[25]  C. Pellegrini,et al.  Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases , 2019, International journal of molecular sciences.

[26]  Chong-Jen Yu,et al.  NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility , 2019, Scientific Reports.

[27]  Chien-Chang Lee,et al.  Integrative Genome-Wide Association Studies of eQTL and GWAS Data for Gout Disease Susceptibility , 2019, Scientific Reports.

[28]  M. Chou,et al.  The Interaction between Sex and Hyperlipidemia on Gout Risk Is Modulated by HLA-B Polymorphic Variants in Adult Taiwanese , 2019, Genes.

[29]  M. Netea,et al.  Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression , 2019, Arthritis Research & Therapy.

[30]  P. Ghezzi,et al.  Secretion of IL-1β From Monocytes in Gout Is Redox Independent , 2019, Front. Immunol..

[31]  N. Van Hai,et al.  Polymorphisms of ABCG2 and SLC22A12 Genes Associated with Gout Risk in Vietnamese Population , 2019, Medicina.

[32]  B. Christensen,et al.  NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease , 2018, npj Parkinson's Disease.

[33]  Y. Qing,et al.  Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population , 2017, Clinical Rheumatology.

[34]  Y. Ding,et al.  Investigation on the association between NLRP3 gene polymorphisms and susceptibility to primary gout. , 2015, Genetics and molecular research : GMR.

[35]  W. Lin,et al.  rs3806268 of NLRP3 gene polymorphism is associated with the development of primary gout. , 2015, International journal of clinical and experimental pathology.

[36]  A. Ogdie,et al.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative , 2015, Annals of the rheumatic diseases.